Ads
related to: Novavax Stock
Search results
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
AOL· 1 day agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine giant Sanofi (SNY) would invest $1.2 billion in a deal for ...
Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
The Wall Street Journal· 1 day agoNovavax shares (NVAX) surged after the vaccine maker said it had struck a licensing deal worth up to...
Why Is Novavax (NVAX) Stock Up 118% Today?
InvestorPlace· 1 day agoNovavax (NASDAQ:NVAX) stock is on the rise Friday after the biotechnology company announced a deal with Sanofi (NASDAQ:SNY) alongside its first-quarter ...
Novavax stock soars 40% on Sanofi partnership
Investing.com· 2 days agoFor the first quarter, Novavax reported a first-quarter loss per share of $1.05, wider than the $0.92 anticipated by analysts. The company's revenue...
Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) delivered earnings and revenue surprises of -0.96% and 7.30%, respectively, for the...
Novavax’s 146% Surge Delivers ‘Rib-Crunching’ Squeeze to Shorts
Bloomberg· 1 day agoHave a confidential tip for our reporters? Novavax Inc.’s record one-day gain is forcing some short...
Novavax Stock Surges 120% on $1.4 Billion Deal With Sanofi
Barrons.com· 1 day agoThe two companies will work on a shot that combines Covid-19 and flu vaccines.Read the full article
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 1 day agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
Novavax stock soars 120% as Sanofi deal 'kicks off a new chapter' By Investing.com
Investing.com· 2 days agoFor the first quarter, Novavax reported a first-quarter loss per share of $1.05, wider than the...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 1 day ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
